Agriculture and Forestry, Art, Design and Architecture, Business and Management, Economics and Econometrics, Education, Engineering and Technology, History, Philosophy, Theology, Law, Medicine and Health Sciences, Natural Sciences and Social Sciences and their 256 sub-branches can analyse the world, countries and regions. You can also analyse them according to i10 index and citation numbers. *Jul 17, 2024 According to Total H Index. BETA VERSION. Subject field ranking in world, region, country and university is beta version since subject field 'others' (655.735) scientists profile whose branch cannot be determined, not yet edited or determined) is excluded, so the ranking will change as the others fields are edited. Please note that. See also: University Subject Rankings
AD Scientific Index - Subject Rankings - 2024 | H INDEX | i10 INDEX | CITATION | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
University / Institution |
Country | Region | World | Name | Country | University / Institution | Subject | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total | Total | Last 6 year | Last 6 year/total |
1 | 550 | 591 | 1,315 |
![]() |
![]() |
![]() |
Others
diabetes | clinical trials | epidemiology | genetics | |
160 | 73 | 0.456 | 566 | 373 | 0.659 | 145,067 | 32,848 | 0.226 |
2 | 1,278 | 1,370 | 2,751 |
|
![]() |
![]() |
Others
Rheumatic diseases | |
134 | 53 | 0.396 | 404 | 178 | 0.441 | 90,109 | 15,014 | 0.167 |
4 | 2,082 | 2,243 | 4,487 |
|
![]() |
![]() |
Others
Diabetic Kidney Disease | |
118 | 73 | 0.619 | 336 | 250 | 0.744 | 184,421 | 80,755 | 0.438 |
5 | 2,566 | 2,763 | 5,534 |
|
![]() |
![]() |
Others
glomerulus | scarring | APOL1 | TGFbeta | |
112 | 69 | 0.616 | 343 | 245 | 0.714 | 44,786 | 16,857 | 0.376 |
6 | 3,443 | 3,740 | 7,436 |
|
![]() |
![]() |
Others
GPCRs | glucose and energy homeostasis | diabetes | |
104 | 50 | 0.481 | 311 | 213 | 0.685 | 35,241 | 9,353 | 0.265 |
7 | 5,996 | 6,542 | 13,214 |
|
![]() |
![]() |
Others
Lysosomal storage diseases | Sphingolipid metabolism | |
89 | 49 | 0.551 | 176 | 134 | 0.761 | 45,139 | 14,086 | 0.312 |
9 | 10,025 | 11,017 | 23,044 |
|
![]() |
![]() |
Others
Obesity | diabetes | energy metabolism | |
76 | 39 | 0.513 | 147 | 95 | 0.646 | 34,436 | 6,634 | 0.193 |
11 | 14,705 | 16,294 | 35,264 |
|
![]() |
![]() |
Others
Liver Disease | |
66 | 47 | 0.712 | 165 | 135 | 0.818 | 19,690 | 10,796 | 0.548 |
12 | 15,352 | 17,021 | 37,011 |
|
![]() |
![]() |
Others
Obesity | energy expenditure | physical activity | body composition | |
65 | 45 | 0.692 | 123 | 110 | 0.894 | 22,146 | 11,722 | 0.529 |
13 | 18,138 | 20,162 | 44,485 |
|
![]() |
![]() |
Others
Transcription & chromatin | Enhancer regulation | Methylation | MLL4 & UTX | Differentiation & development | |
61 | 48 | 0.787 | 96 | 92 | 0.958 | 14,788 | 8,087 | 0.547 |
![]() |
Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages |
![]() |
||||||||||||||
14 | 18,993 | 21,126 | 46,889 |
|
![]() |
![]() |
Others
metabolism | body weight | body composition | energy expenditure | |
60 | 45 | 0.750 | 113 | 90 | 0.796 | 25,579 | 14,755 | 0.577 |
15 | 31,950 | 35,915 | 85,838 |
|
![]() |
![]() |
Others
diabetes | epidemiology | |
48 | 36 | 0.750 | 95 | 83 | 0.874 | 14,184 | 9,104 | 0.642 |
16 | 40,333 | 45,485 | 113,116 |
|
![]() |
![]() |
Others
dynamin | |
43 | 29 | 0.674 | 51 | 43 | 0.843 | 11,219 | 3,124 | 0.278 |
19 | 52,974 | 59,881 | 156,975 |
|
![]() |
![]() |
Others
Cardiovascular Disease/Obesity/Diabetes | |
37 | 27 | 0.730 | 69 | 51 | 0.739 | 10,368 | 4,373 | 0.422 |
20 | 53,481 | 60,472 | 158,804 |
|
![]() |
![]() |
Others
Biophysics | NMR spectroscopy | |
37 | 24 | 0.649 | 63 | 38 | 0.603 | 4,463 | 2,079 | 0.466 |
21 | 59,388 | 67,212 | 180,185 |
|
![]() |
![]() |
Others
|
35 | 19 | 0.543 | 53 | 25 | 0.472 | 4,390 | 1,210 | 0.276 |
24 | 68,812 | 77,886 | 214,395 |
|
![]() |
![]() |
Others
|
32 | 19 | 0.594 | 48 | 28 | 0.583 | 4,791 | 1,258 | 0.263 |
27 | 71,752 | 81,222 | 225,089 |
|
![]() |
![]() |
Others
Sphingolipids | |
31 | 22 | 0.710 | 37 | 30 | 0.811 | 8,201 | 2,298 | 0.280 |
28 | 75,021 | 84,918 | 237,355 |
|
![]() |
![]() |
Others
GPCR | mouse model | |
30 | 23 | 0.767 | 38 | 36 | 0.947 | 3,199 | 1,459 | 0.456 |
29 | 79,318 | 89,794 | 253,999 |
|
![]() |
![]() |
Others
Sphingolipids | Signaling | Human disease | Gene therapy | |
29 | 21 | 0.724 | 36 | 25 | 0.694 | 4,337 | 1,498 | 0.345 |
30 | 81,786 | 92,569 | 263,346 |
|
![]() |
![]() |
Others
Diabetes | |
28 | 25 | 0.893 | 43 | 41 | 0.953 | 4,257 | 3,929 | 0.923 |
33 | 102,296 | 115,788 | 343,612 |
|
![]() |
![]() |
Others
obesity | diabetes | aging | |
24 | 20 | 0.833 | 37 | 33 | 0.892 | 1,914 | 1,580 | 0.825 |
36 | 109,113 | 123,431 | 370,252 |
|
![]() |
![]() |
Others
|
23 | 18 | 0.783 | 35 | 27 | 0.771 | 4,267 | 1,734 | 0.406 |
37 | 132,376 | 149,539 | 462,915 |
|
![]() |
![]() |
Others
|
20 | 13 | 0.650 | 26 | 20 | 0.769 | 1,007 | 543 | 0.539 |
39 | 145,769 | 164,448 | 515,116 |
|
![]() |
![]() |
Others
Cardiovascular diseases | obesity | T2DM | |
18 | 16 | 0.889 | 20 | 18 | 0.900 | 1,048 | 837 | 0.799 |